Räsänen J, Helisalmi S, Heikkinen S, et al. Low prevalence of CWH43 variants among Finnish and Norwegian idiopathic normal pressure hydrocephalus patients: a cohort-based observational study. Fluids and barriers of the CNS. 2025;22(1):17. doi:10.1186/s12987-025-00625-0
Publications
Räsänen J, Helisalmi S, Heikkinen S, et al. Low prevalence of CWH43 variants among Finnish and Norwegian idiopathic normal pressure hydrocephalus patients: a cohort-based observational study. Fluids and barriers of the CNS. 2025;22(1):17. doi:10.1186/s12987-025-00625-0
Cho SMJ, Urbut S, Ruan Y, et al. East and South Asian-Specific Blood Pressure Trajectories and Cardiovascular Disease. Hypertension (Dallas, Tex. : 1979). 2025. doi:10.1161/HYPERTENSIONAHA.124.23985
Ugai S, Liu L, Kosumi K, et al. Long-term yogurt intake and colorectal cancer incidence subclassified by abundance in tumor. Gut microbes. 2025;17(1):2452237. doi:10.1080/19490976.2025.2452237
Bunting EL, Donaldson J, Cumming SA, et al. Antisense oligonucleotide-mediated MSH3 suppression reduces somatic CAG repeat expansion in Huntington’s disease iPSC-derived striatal neurons. Science translational medicine. 2025;17(785):eadn4600. doi:10.1126/scitranslmed.adn4600
Sayadi A, Sandling JK, Eloranta ML, et al. Rare and common single nucleotide variants in childhood-onset systemic lupus erythematosus. Lupus science & medicine. 2025;12(1). doi:10.1136/lupus-2024-001436
Schiantarelli J, Benamar M, Park J, et al. Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma. Cancer cell. 2025;43(2):308-316.e6. doi:10.1016/j.ccell.2025.01.009
Nagai TH, Mizoguchi T, Wang Y, et al. ANGPTL3 regulates the peroxisomal translocation of SmarcAL1 in response to cell growth states. Scientific reports. 2025;15(1):5036. doi:10.1038/s41598-025-89552-6
Chen Y, Lee K, Woo J, et al. Evaluating predictors of kinase activity of STK11 variants identified in primary human non-small cell lung cancers. Human genetics. 2025. doi:10.1007/s00439-025-02726-0
Frigault MJ, Yao E, Berger TR, et al. Single-cell dynamics of breakthrough toxicities following anakinra prophylaxis for axicabtagene ciloleucel in lymphoma. Blood advances. 2025. doi:10.1182/bloodadvances.2024015161